Skip to main content

Animations

MJFF Publications

6431 - 6440 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2023
  • 2016
  • 2021
  • 2024
  • 2022
  • 2016
  • 2024
  • 2023
  • 2015
  • Summary Details
    OPEN
    Title: Proteolytic activities of extracellular vesicles attenuate A-synuclein aggregation
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01122-9
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Biologic targets of prescription medications and risk of neurodegenerative disease in United States Medicare beneficiaries
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0285011
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian rats
    Journal Name: Pharmacology Biochemistry and Behavior
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pbb.2016.01.004
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s Disease
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acsnano.1c00453
    Citation Count: 79
  • Summary Details
    RESTRICTED
    Title: Conquering Neurologic Diseases in Primary Care
    Journal Name: Primary Care: Clinics in Office Practice
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pop.2024.03.001
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Frontostriatal and limbic contributions to cognitive decline in Parkinson's disease
    Journal Name: Journal of Neuroimaging
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/jon.13045
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Weighted Protein Interaction Network Analysis of Frontotemporal Dementia
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.6b00934
    Citation Count: 41
  • Summary Details
    RESTRICTED
    Title: Symmetry of synuclein density in autopsied Parkinson’s disease submandibular glands
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.neulet.2024.137702
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Measuring Up: A Comparison of TapeStation 4200 and Bioanalyzer 2100 as Measurement Tools for RNA Quality in Postmortem Human Brain Samples
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms241813795
    Citation Count: 10
  • Summary Details
    OPEN
    Title: A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2015.09.015
    Citation Count: 45
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.